Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome

Por Dostalova Merkerova, Michaela, Krejcik, Zdenek, Votavova, Hana, Belickova, Monika, Vasikova, Alzbeta, Cermak, Jaroslav
Publicado em 2011

Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome

Por Votavova, Hana, Grmanova, Martina, Dostalova Merkerova, Michaela, Belickova, Monika, Vasikova, Alzbeta, Neuwirtova, Radana, Cermak, Jaroslav
Publicado em 2011

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population

Por Belickova, Monika, Merkerova, Michaela Dostalova, Stara, Eliska, Vesela, Jitka, Sponerova, Dana, Mikulenkova, Dana, Brdicka, Radim, Neuwirtova, Radana, Jonasova, Anna, Cermak, Jaroslav
Publicado em 2013

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes

Por Belickova, Monika, Vesela, Jitka, Jonasova, Anna, Pejsova, Barbora, Votavova, Hana, Merkerova, Michaela Dostalova, Zemanova, Zuzana, Brezinova, Jana, Mikulenkova, Dana, Lauermannova, Marie, Valka, Jan, Michalova, Kyra, Neuwirtova, Radana, Cermak, Jaroslav
Publicado no Oncotarget (2016)